BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1677981)

  • 1. Are transplanted tumours suitable as models for studies on vasculature?
    Field SB; Burney IA; Needham S; Maxwell RJ; Coggle J; Griffiths JR
    Int J Radiat Biol; 1991; 60(1-2):255-60. PubMed ID: 1677981
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in vascular response between primary and transplanted tumours.
    Field SB; Needham S; Burney IA; Maxwell RJ; Coggle JE; Griffiths JR
    Br J Cancer; 1991 May; 63(5):723-6. PubMed ID: 1645562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
    Horsman MR; Nordsmark M; Høyer M; Overgaard J
    Br J Cancer; 1995 Dec; 72(6):1474-8. PubMed ID: 8519662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumours.
    Smith TA; Baluch S; Titley JC; Ormerod MG; Eccles S; Tombs AJ; Leach MO; Griffiths JR; McCready VR
    NMR Biomed; 1993; 6(3):209-14. PubMed ID: 8347455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The energy metabolism of RIF-1 tumours following hydralazine.
    Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR
    Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.
    Fenton BM
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):799-808. PubMed ID: 11172963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI.
    Wang Z; Su MY; Najafi A; Nalcioglu O
    Magn Reson Imaging; 2001 Oct; 19(8):1063-72. PubMed ID: 11711230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the microvasculature in experimental mammary tumors in C3H mice to selected vasoactive drugs.
    Puffer HW; Warner NE
    Proc West Pharmacol Soc; 1975; 18():133-5. PubMed ID: 1237136
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
    Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR
    Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of intratumor pH by pH indicator used in 19F-magnetic resonance spectroscopy. Measurement of extracellular pH decrease caused by hyperthermia combined with hydralazine.
    Aoki Y; Akagi K; Tanaka Y; Kawai J; Takahashi M
    Invest Radiol; 1996 Nov; 31(11):680-9. PubMed ID: 8915749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR; Christensen KL; Overgaard J
    Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.
    Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC
    Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure.
    Horsman MR; Christensen KL; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):455-8. PubMed ID: 1735677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Thomas C; Counsell C; Wood P; Adams GE
    J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methylnitrosourea induced breast cancer in rat, the histopathology of the resulting tumours and its drawbacks as a model.
    Perse M; Cerar A; Injac R; Strukelj B
    Pathol Oncol Res; 2009 Mar; 15(1):115-21. PubMed ID: 18985443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours.
    Denis F; Bougnoux P; de Poncheville L; Prat M; Catroux R; Tranquart F
    Ultrasound Med Biol; 2002 Apr; 28(4):431-7. PubMed ID: 12049955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ON TRANSPLANTATION OF "RADIATION" TUMORS OF MAMMARY GLANDS IN RATS].
    PONOMARKOV VI
    Biull Eksp Biol Med; 1963 Aug; 56():85-8. PubMed ID: 14090483
    [No Abstract]   [Full Text] [Related]  

  • 18. Preclinical approaches to the development of effective immunotherapeutic protocols for the treatment of metastasis.
    Talmadge JE
    Prog Clin Biol Res; 1986; 212():197-215. PubMed ID: 3520577
    [No Abstract]   [Full Text] [Related]  

  • 19. Fasting during promotion, but not during initiation, enhances the growth of methylnitrosourea-induced mammary tumours.
    Tessitore L; Chiara M; Sesca E; Premoselli F; Binasco V; Dianzani MU
    Carcinogenesis; 1997 Aug; 18(8):1679-81. PubMed ID: 9276649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-frequency electromagnetic radiation enhances the induction of rat mammary tumors by nitrosomethyl urea.
    Beniashvili DS; Bilanishvili VG; Menabde MZ
    Cancer Lett; 1991 Dec; 61(1):75-9. PubMed ID: 1764700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.